Rigoberto Hernandez-Castro, Roberto Arenas, Israel Esquivel-Pinto, Teerapong Rattananukrom
{"title":"从石蜡包埋的人体皮肤活检和临床病理分析中鉴定出嗜色母菌病中的嗜色母菌。","authors":"Rigoberto Hernandez-Castro, Roberto Arenas, Israel Esquivel-Pinto, Teerapong Rattananukrom","doi":"10.1093/mmy/myaf055","DOIUrl":null,"url":null,"abstract":"<p><p>Chromoblastomycosis (CBM) is a chronic fungal infection caused by dematiaceous fungi. In some cases, culture methods fail to identify the fungal species, and fresh tissue for molecular identification is unavailable. The use of molecular techniques on formalin-fixed, paraffin-embedded (FFPE) samples can aid in identifying the causative agent. This study aimed to identify fungal species in histopathologically confirmed cases of CBM using PCR and sequencing of 18S-ITS1-5.8S-ITS2-28S rDNA region of FFPE skin biopsies and to describe their clinicopathological features. This retrospective study used FFPE samples from nine CBM patients from remote regions of Mexico. The samples were submitted to the Mycology Section at the Hospital General \"Dr. Manuel Gea González\" (2000-2016) for molecular identification of the causative agent and characterization of clinicopathological features. Lesions were most commonly located on the forearm (four cases), with one case each on the buttock, back, foot, and leg. One patient presented with cutaneous dissemination. Verrucous plaques were observed in 88.9% of cases. Histology and direct examination confirmed CBM, showing muriform cells and varying degrees of dermal fibrosis in all cases. DNA extracted from FFPE samples was amplified and sequenced in the 18S-ITS1-5.8S-ITS2-28S rDNA region, identifying Fonsecaea pedrosoi with 100% homology in all cases. This study identifies F. pedrosoi as the predominant pathogen of CBM in the evaluated samples of Mexican origin and demonstrates the reliability of molecular identification using FFPE samples.</p>","PeriodicalId":18586,"journal":{"name":"Medical mycology","volume":" ","pages":""},"PeriodicalIF":2.3000,"publicationDate":"2025-07-02","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":"{\"title\":\"Molecular identification of Fonsecaea pedrosoi in chromoblastomycosis: Insights from paraffin-embedded human skin biopsies and clinicopathology.\",\"authors\":\"Rigoberto Hernandez-Castro, Roberto Arenas, Israel Esquivel-Pinto, Teerapong Rattananukrom\",\"doi\":\"10.1093/mmy/myaf055\",\"DOIUrl\":null,\"url\":null,\"abstract\":\"<p><p>Chromoblastomycosis (CBM) is a chronic fungal infection caused by dematiaceous fungi. In some cases, culture methods fail to identify the fungal species, and fresh tissue for molecular identification is unavailable. The use of molecular techniques on formalin-fixed, paraffin-embedded (FFPE) samples can aid in identifying the causative agent. This study aimed to identify fungal species in histopathologically confirmed cases of CBM using PCR and sequencing of 18S-ITS1-5.8S-ITS2-28S rDNA region of FFPE skin biopsies and to describe their clinicopathological features. This retrospective study used FFPE samples from nine CBM patients from remote regions of Mexico. The samples were submitted to the Mycology Section at the Hospital General \\\"Dr. Manuel Gea González\\\" (2000-2016) for molecular identification of the causative agent and characterization of clinicopathological features. Lesions were most commonly located on the forearm (four cases), with one case each on the buttock, back, foot, and leg. One patient presented with cutaneous dissemination. Verrucous plaques were observed in 88.9% of cases. Histology and direct examination confirmed CBM, showing muriform cells and varying degrees of dermal fibrosis in all cases. DNA extracted from FFPE samples was amplified and sequenced in the 18S-ITS1-5.8S-ITS2-28S rDNA region, identifying Fonsecaea pedrosoi with 100% homology in all cases. This study identifies F. pedrosoi as the predominant pathogen of CBM in the evaluated samples of Mexican origin and demonstrates the reliability of molecular identification using FFPE samples.</p>\",\"PeriodicalId\":18586,\"journal\":{\"name\":\"Medical mycology\",\"volume\":\" \",\"pages\":\"\"},\"PeriodicalIF\":2.3000,\"publicationDate\":\"2025-07-02\",\"publicationTypes\":\"Journal Article\",\"fieldsOfStudy\":null,\"isOpenAccess\":false,\"openAccessPdf\":\"\",\"citationCount\":\"0\",\"resultStr\":null,\"platform\":\"Semanticscholar\",\"paperid\":null,\"PeriodicalName\":\"Medical mycology\",\"FirstCategoryId\":\"3\",\"ListUrlMain\":\"https://doi.org/10.1093/mmy/myaf055\",\"RegionNum\":3,\"RegionCategory\":\"医学\",\"ArticlePicture\":[],\"TitleCN\":null,\"AbstractTextCN\":null,\"PMCID\":null,\"EPubDate\":\"\",\"PubModel\":\"\",\"JCR\":\"Q3\",\"JCRName\":\"INFECTIOUS DISEASES\",\"Score\":null,\"Total\":0}","platform":"Semanticscholar","paperid":null,"PeriodicalName":"Medical mycology","FirstCategoryId":"3","ListUrlMain":"https://doi.org/10.1093/mmy/myaf055","RegionNum":3,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q3","JCRName":"INFECTIOUS DISEASES","Score":null,"Total":0}
引用次数: 0
摘要
成色菌病(CBM)是一种由赤色真菌引起的慢性真菌感染。在某些情况下,培养方法无法识别真菌种类,并且无法获得用于分子鉴定的新鲜组织。对福尔马林固定石蜡包埋(FFPE)样品使用分子技术可以帮助鉴定病原体。本研究旨在通过PCR和FFPE皮肤活检18S-ITS1-5.8S-ITS2-28S rDNA区测序,鉴定组织病理学确诊的CBM病例中的真菌种类,并描述其临床病理特征。这项回顾性研究使用了来自墨西哥偏远地区的9名CBM患者的FFPE样本。样本提交给医院总医院“Dr. Manuel Gea González”真菌学科(2000-2016),用于病原体的分子鉴定和临床病理特征的表征。病变最常见于前臂(4例),臀部、背部、足部和腿部各1例。1例患者出现皮肤播散。88.9%的病例出现疣状斑块。组织学和直接检查证实CBM,所有病例均表现为多形态细胞和不同程度的真皮纤维化。从FFPE样品中提取的DNA进行扩增,并对18S-ITS1-5.8S-ITS2-28S rDNA区域进行测序,所有病例的Fonsecaea pedrosoi同源性均为100%。本研究确定了墨西哥原产样品中的主要病原菌为灰化梭菌,并证明了用FFPE样品进行分子鉴定的可靠性。
Molecular identification of Fonsecaea pedrosoi in chromoblastomycosis: Insights from paraffin-embedded human skin biopsies and clinicopathology.
Chromoblastomycosis (CBM) is a chronic fungal infection caused by dematiaceous fungi. In some cases, culture methods fail to identify the fungal species, and fresh tissue for molecular identification is unavailable. The use of molecular techniques on formalin-fixed, paraffin-embedded (FFPE) samples can aid in identifying the causative agent. This study aimed to identify fungal species in histopathologically confirmed cases of CBM using PCR and sequencing of 18S-ITS1-5.8S-ITS2-28S rDNA region of FFPE skin biopsies and to describe their clinicopathological features. This retrospective study used FFPE samples from nine CBM patients from remote regions of Mexico. The samples were submitted to the Mycology Section at the Hospital General "Dr. Manuel Gea González" (2000-2016) for molecular identification of the causative agent and characterization of clinicopathological features. Lesions were most commonly located on the forearm (four cases), with one case each on the buttock, back, foot, and leg. One patient presented with cutaneous dissemination. Verrucous plaques were observed in 88.9% of cases. Histology and direct examination confirmed CBM, showing muriform cells and varying degrees of dermal fibrosis in all cases. DNA extracted from FFPE samples was amplified and sequenced in the 18S-ITS1-5.8S-ITS2-28S rDNA region, identifying Fonsecaea pedrosoi with 100% homology in all cases. This study identifies F. pedrosoi as the predominant pathogen of CBM in the evaluated samples of Mexican origin and demonstrates the reliability of molecular identification using FFPE samples.
期刊介绍:
Medical Mycology is a peer-reviewed international journal that focuses on original and innovative basic and applied studies, as well as learned reviews on all aspects of medical, veterinary and environmental mycology as related to disease. The objective is to present the highest quality scientific reports from throughout the world on divergent topics. These topics include the phylogeny of fungal pathogens, epidemiology and public health mycology themes, new approaches in the diagnosis and treatment of mycoses including clinical trials and guidelines, pharmacology and antifungal susceptibilities, changes in taxonomy, description of new or unusual fungi associated with human or animal disease, immunology of fungal infections, vaccinology for prevention of fungal infections, pathogenesis and virulence, and the molecular biology of pathogenic fungi in vitro and in vivo, including genomics, transcriptomics, metabolomics, and proteomics. Case reports are no longer accepted. In addition, studies of natural products showing inhibitory activity against pathogenic fungi are not accepted without chemical characterization and identification of the compounds responsible for the inhibitory activity.